VCELVericel Corporation

$2B

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$19,000-9.5% YoY

Gross Profit

$15,00078.9% margin

Operating Income

-$21M-110336.8% margin

Net Income

-$16M-82221.1% margin

EPS (Diluted)

$-5.18

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$926,000

Balance Sheet

Total Assets

$9M

Total Liabilities

$5M

Stockholders' Equity

$4M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19,000	$21,000	-9.5%
Gross Profit	$15,000	$15,000	+0.0%
Operating Income	-$21M	-$34M	+37.9%
Net Income	-$16M	-$29M	+47.0%

VCEL FY 2013 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena